645.7000 -5.35 (-0.82%)
NSE Jan 16, 2026 15:31 PM
Volume: 208.4K
 

645.70
-0.82%
Axis Direct
We retain our BUY rating on the stock with a target price of Rs 850/share, implying an upside potential of 19% from the CMP.
Number of FII/FPI investors increased from 104 to 115 in Sep 2025 qtr.
More from Healthcare Global Enterprises Ltd.
All Rapid Results
Recommended